cancer

The award from the National Cancer Institute will fund a series of collaborative research projects over five years at UCLA.

The immunotherapy drug combination is currently being reviewed for approval under a new FDA pilot program.

By repurposing drugs originally intended for other uses, scientists are pushing forward the fight against cancer.

“We hope our method could be used in the future to prepare treatments that can be performed at the patient’s bedside,” said UCLA’s Paul Weiss.

Research brief: The experiment represents one of a very few instances in which a drug reduced cognitive decline in animals after radiation treatment.

A Q&A with Dr. Eric Esrailian on the  Robert G. Kardashian Center for Esophageal Health and outreach efforts around COVID-19.

A UCLA study shows that radiation therapy can be cut from five weeks to five days.

The patch significantly prolonged survival and reduced the growth of tumors in mice.

Research brief: The drug is made up of compounds produced by plants, including curcumin. Curcumin has been tested to help fight multiple cancers because it is an antioxidant that reduces swelling and inflammation.

Research brief: When tested in mice with melanoma tumors that were unlikely to stimulate an immune response, the approach increased the number of anti-tumor immune cells.

The funds will help the Simms/Mann–UCLA Center for Integrative Oncology expand its reach to community clinics.

The drug combination should be a first line of treatment, UCLA researchers say.

A combination approach could be new strategy for people with advanced cancers.

Scientists from 22 institutions, including UCLA, call for early diagnosis, prevention and treatment to reduce the risk of chronic diseases.

Research brief: The new method, using robotics, will speed up how researchers test for therapies that block the metabolism of non-small-cell lung cancer tumors.

The finding could lead to better treatments for leukemia and other blood diseases.

Report from Web of Science Group identifies researchers in 21 fields whose work was most often referenced by other papers.

UCLA graduate student Cody Aros is helping make science and medicine more inclusive for LGBTQ-identifying people.

Funds from California’s stem cell agency will support research on a blinding eye disease, cancer and an immune disorder.

The funds will help advance work in diagnosis, prognosis and treatment of the disease

The study demonstrates that PET imaging can be used to read mitochondrial activity in lung tumors.

The study, conducted in mice, is the first to show that creatine uptake is critical to the anti-tumor activities of what is known as killer T cells, the foot soldiers of the immune system.

In most people with chronic myelogenous leukemia, cancerous stem cells remain in the body for years after remission, and the cancer can recur.

When reviewers were subspeciality-trained, misclassification rates were the lowest.

The finding suggests that predicting how a person’s cancer will evolve may lie in their inherited genetic material.